You are invited to participate, bring your staff and colleagues to initiate better standard of care access for cancer patients in Connecticut.
CONNECTICUT ONCOLOGY ASSOCIATION MEETING
Meeting Date: Wed. Feb. 5, 2025 Time: Evening Meeting 6 pm to 8:30 pm
Location: Sheraton Hartford South (formerly Rocky Hill Marriott) Rocky Hill
6 pm registration, 6:20 buffet dinner, 6:40 meeting starts
Topic “CT MD Perspectives – Opportunities in Multiple Myeloma”. Please join notable physician leaders from Connecticut as they share their thoughts on clinical and operational opportunities related to multiple myeloma treatments. We hope for a robust interactive discussion – and perhaps to develop an ongoing patient care networking among CT cancer centers. Topics will include:
- · Current treatments for newly diagnosed patients
- · What can be done when patients relapse/progress
- · Current treatments in second line and beyond, including car-t, bispecifics, etc.
- · What is exciting about potential future treatments
Panelists:
Syed Saqib Ali, MD Dr. Ali specializes in Hematology & Medical Oncology at Trinity Health of New England Medical Group in Hartford.
Dinesh Kapur, MD Dr. Kapur is the President of the Connecticut Oncology Association, practicing at Eastern Connecticut Hematology and Oncology. Dr. Kapur is chair of OneCouncil, the OneOncology partnership's all-physician advisory board for clinical and strategic initiatives.
Swarup Kumar, MD Dr. Kumar is a Hematologist at the University of Connecticut Health Center.
Natalia Neparidze, MD Dr. Neparidze is an Associate Professor of Internal Medicine (Hematology) and Research Leader - Myeloma Program, Hematology at Yale School of Medicine.
This is a not to be missed program for physicians and staff in every group in CT (hospital based or private.). You may register on the CT Oncology Association website, www.ctoncology.com, or by email to dawnho@aol.com.
We will also be discussing plans for the Connecticut Oncology Association projects and meetings in 2024, and look forward to participation from practice physicians, administration and nurses. All are encouraged to attend. We also extend a warm welcome to any Residents or Fellows who wish to join us.
Please join the Connecticut Oncology Association in thanking our 2024 Charter Oak Partners (2025 Partners are in process) for helping us to bring these education programs to our members: AstraZeneca, Bristol Myers Squibb, Daiichi Sankyo, Exelixis, Genentech, Merck, Sanofi Genzyme, Seattle Genetics, Taiho Oncology, and Takeda.
We would also like to thank our other 2024 Nutmeg level corporate partners: Abbvie, Astellas, Eisai, Johnson & Johnson, Incyte, Novartis, Pfizer, and PharmaEssentia.
We look forward to welcoming these partners and others in 2025. 2025 Corporate Partner Invitations/Information are now available on our web site, www.ctoncology.com .
Please Complete & email the Registration Information Below by Friday, Jan. 31. at noon.
I will be attending the CtOA meeting at 6 pm Yes____ No___
Please register at www.ctoncology.com, Or email to dawnho@aol.com
It is important to provide contact phone and email information, in case of adverse weather or unexpected issues.
Name: ____________ Affiliation:______________________________
Contact Phone #:_______________ Contact Email _____________________
All Staff and Physicians for Connecticut Practices are members of the Connecticut Oncology Association and invited to participate at no charge.
Thanks, Dawn
Dawn Holcombe, MBA FACMPE ACHE
Executive Director, Connecticut Oncology Association
dawnho@aol.com (main)
860-305-4510 (cell and main)
www.ctoncology.com
